Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study.
作者信息
Michon J, Négrier S, Coze C, Mathiot C, Frappaz D, Oskam R, Pacquement H, Quintana E, Bouffet E, Bernard J L